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Analysis for the prognosis of young women with lung  
adenocarcinoma 
Liu, Ming; Jiang, Ge N.; Ding, Jia A. 
Shanghai Pulmonary Hospital, Shanghai, China
Background: With the increasing of smokers, the mortality of women 
with lung cancer is raising in the world. Although incidence of young 
women with lung adenocarcinoma is low, the clinical characteristic is 
signiﬁcant to the prognostic. 
Methods: A total 282 surgically treated patients with lung adenocarci-
noma were analyzed retrospectively. Kaplan-Meier and Cox regression 
were used to analyze the relationship between the prognostic factors 
and survival time.
Results: Kaplan-Meier analysis showed that at 5 years the survival 
were 20.0% for smokers and 36.4% for non-smokers (P=0.021). The 
5-year survival rates of staging I, II, III, IV were 65.7%(1a 66.1%, Ib 
60.5%),30.9%(IIa 36.3%, IIb 27.5%), 11.4%(IIIa 12.3%, IIIb 6.8%) 
and 3.6%, respectively (P<0.001),the survival rates of the number of 
involved lymph nodes>3 and ≤3 were 19.1% and 38.3% (P=0.006), and 
the survival rates of different differentiation were 65.2%, 29.5% and 
19.8% (P<0.001). Multivariate analysis indicated that smoking p-TNM 
and differentiation were independent prognostic factor the relative risk 
(RR) was 3.315 2.809 and 1.195 respectively. 
Conclusions: Smoking, p-TNM, the number of involved lymph nodes 
and differentiation were correlated with the survival. Smoking, p-TNM 
and differentiation were independent prognostic factor for the survival 
of young women with lung adenocarcinoma, comprehensive smoking 
control efforts and total lymphadenectomy are important to the survival 
of lung adenocarcinoma among young women.
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Clinical analysis of adjuvant chemotherapy after radical surgery 
for stage II non-small cell lung cancer
Liu, Shun S. 
Liaoning Province Cancer Hospital, Shenyang, China
Objective: To evaluate the efﬁcacy of adjuvant chemotherapy after 
radical surgery for stage II non-small cell lung cancer(NSCLC). 
Methods: 429 patients with stage III NSCLC undergone radical sur-
gery were involved. 198 cases received surgery along (surgery group). 
The other 231 patients received 3 or 4 cycles of adjuvant chemotherapy 
after resection (adjuvant chemotherapy group): 72 cases with MVP, 89 
patients with CAP and 70 patients with NP. 
Results: In patients with stage IIA NSCLC, the 5-year survival rate 
was 48.96% in adjuvant chemotherapy group and 41.86% in the sur-
gery group. There was no statistical discrepancy (P>0.05). In patients 
with stage IIB NSCLC, the 5-year survival rate was 42.96% in adjuvant 
chemotherapy group and 30.35% in surgery group, respectively. The 
difference between the two groups was statistically signiﬁcant(P<0.05).
the 5-year survival rates of MVP and CAP chemotherapy groups were 
41.37% and 44.44% in stage IIA NSCLC, 37.21% and 37.74 % in stage 
IIB NSCLC. Compared with the 5-year survival rates of the IIA and 
IIB surgery groups, there was no statistical difference(P>0.05). the 5-
year survival rates of NP chemotherapy group were 63.33% in IIA and 
55% in IIB, respectively. There was signiﬁcant discrepancy between 
NP groups and surgery groups in stage IIA and IIB (P<0.05). 
Conclusion: Postoperative adjuvant chemotherapy with NP regimen 
for 3 or 4 cycles can increase survival rate for stage II NSCLC patients.
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Survival improvement during two decades in stage IIIA NSCLC 
patients from single institution
Lu, Shun; Yu, Yong-Feng; Li, Zi-Ming 
Shanghai Lung Cancer Center, Shanghai Chest Hospital, Jiao Tong 
University, Shanghai, China
Objective: To explore survival improvement over last two decades and 
study the effect of multimodality therapy in stage IIIA lung cancer in 
single institution.
Methods: The clinic data and survival information of 2,450 patients 
with operable stage IIIA lung cancer was collected. These patients were 
divided into two groups. Group A consisted of 1,004 patients who were 
admitted in Shanghai Chest Hospital from 1980s. Group B consisted 
of 1,446 patients who were treated in Shanghai Chest Hospital from 
the past ten years. The software SPSS10.0 was utilized in statistical 
analysis.
Results: Adjuvant therapy was rare in group A. Most of the patients 
in group B accepted multimodality therapy. Both of the two group 
contained a few small cell lung cancer, 85 patients(8.4%) in group A 
and 56 patients(3.9%) in group B. Due to adopting old staging critera, 
group A contained 290 patients(28.9%) with stage T3N0M0. The 
3-year survival rates for stage T3N2M0 in group A and B were 10.5% 
and 17.7%,respectively (P<0.01). The 3-year survival rates for stage 
T1,2N2M0 in both group were 24.7% and 25.6%,respectively (P>0.05).
The 3-year survival rates for stage T3N1M0 in both group were 28.5% 
and 24.4%,respectively (P>0.05). 
Conclusion: Compared with other subset of stage IIIA lung cancer, 
multimodality therapy would be more superior to surgical therapy alone 
for the patients with stage T3N2M0.
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Prognostic influencing factors in stage IB non-small cell lung 
cancer
Lu, Shun1 Yu, Yong-Feng2 Li, Zi-Ming2 
1 Shanghai Chest Hospital, Jiao Tong University, Shanghai, China 2 
Shanghai Lung Cancer Center, Shanghai Chest Hospital, Jiao Tong 
University, Shanghai, China 
Objective: To investigate the prognostic inﬂuencing factors in stage IB 
non-small cell lung cancer(NSCLC).
Methods: Sixty-seven NSCLC patients with pathological T2N0 dis-
ease who underwent pulmonary lobectomy from Jun 1,2004 to Dece 
31,2004 in our center were examined. These patients accepted either 
limited lymph node sampling or systematic lymphadenectomy. 392 
lymph nodes in all were resected containing 201 mediastinal nodal 
stations(103 superior mediastinal nodal stations; 98 inferior mediastinal 
nodal stations). The sizes of primary tumors were measured. The status 
of visceral pleura involved by tumor and other relevant factors were ex-
amined. All of the patients were followed up, the last follow up date is 
Jan 1, 2007.The software SPSS10.0 was utilized in statistical analysis. 
Kaplain-Meire was used in survival analysis and Cox Regression was 
adopted to study the relationship between some factors with survival 
time. 
